«
October 2006
Acomplia – Works Doubly as Weight Loss and
Anti Smoking Pill
October 05, 2006
Not all discoveries are planned. Many a times results of
research amaze the researcher itself. A similar instance
was noticed when research was being undertaken on Acomplia
for its weight loss properties. It was observed that the
drug was helpful in reducing cravings for not only food
but also smoking. This was a breakthrough discovery and
was hailed by people all over the world.
Obesity and smoking
are two of the most severe problems grappling the society
today. Today obesity causes the most number of deaths worldwide,
mainly in the form of cardio-vascular complications. Smoking
too contributes to nearly 20% of all deaths. A single pill
to deal with both these problems – people are swooning
over Acomplia’s weight loss and anti-smoking properties.
Acomplia is the brand name of Rimonabant. Developed by Sanofi-Aventis,
rimonabant works by blocking a pleasure centre. This pleasure
centre would get titillated and thus patients would feel
hunger pangs. Researchers at Sanofi-Aventis thought that
if this pleasure centre were blocked, it would reduce cravings
for food. When appetite is dampened, the patient will automatically
lose weight.
The idea for developing the pill came from the observations
in people who smoked cannabis. After a joint of cannabis,
the smokers experienced extreme hunger pangs. Studying the
cause of this led them to the body’s Endocannabinoid
system. Cannabinoid type I or CB1 receptors cause the hunger
pangs. Thus, the idea of blocking the CB1 receptors arose.
While the effectiveness of Acomplia has been fully ascertained
on the weight loss front, research is still being undertaken
on its anti smoking properties.
Read more: http://www.market-day.net/article_30713/20061005/Acomplia-%E2%80%93-Works-Doubly-as-Weight-Loss-and-Anti-Smoking-Pill.php
